Council

President

Neil Gow is a member of the Aberdeen Fungal Group that constitutes one of the largest academic centres for basic research in medical mycology in the world.  He has specific interests in the molecular genetics of cell wall biosynthesis in fungi and the directional growth responses of fungal cells as well as the virulence properties of medically important fungal species.  In recent years he has focussed mainly on the genetics of glycosylation and the fungus-host interaction, and on chitin synthesis and hyphal orientation responses.  He is currently editor in chief of Fungal Genetics and Biology.

 

Contact

Professor Neil A.R. Gow,
CLSM Director of Research,
School of Medical Sciences,
Institute of Medical Sciences,
University of Aberdeen,
Aberdeen AB25 2ZD, UK
Tel: +44-1224-437483
Fax: +44-1224-437465

 

General Secretary

Peter Donnelly is Coordinator of Studies in Supportive Care of the Department of Haematology and is a member of the Nijmegen Institute for Infection Inflammation and Immunity (www.N4i.nl) . He is Chair of the EORTC Infectious Disease Group (www.eortc.org) and of the Steering Committee of the EAPCRI (www.eapcri.eu) , member of the EBMT Infectious Diseases Working Party (www.ebmt.org) and a Senior Editor of the Journal of Antimicrobial Chemotherapy (www.jac.oxfordjournals.org/). His current research interests are the epidemiology, diagnosis and management of invasive fungal diseases, mucosal barrier injury and infection and infectious complications of the neutropenic patient.

 

Contact
Dr J Peter Donnelly BSc PhD FRC Path
Co-ordinator, Studies in Supportive Care
Department of Haematology
Radboud University Nijmegen Medical Centre & Nijmegen Institute for Infection, Inflammation and Immunity
Geert Grooteplein Zuid 8
6525 GA Nijmegen
The Netherlands
Tel: +31-24-361-9987
Fax: +31-24-354-2080

 

Treasurer

Donna MacCallum is a senior lecturer in the School of Medical Sciences and a member of the Aberdeen Fungal Group at the University of Aberdeen, UK. She is a past treasurer of the British Society for Medical Mycology (BSMM) (2004-2012), a current member of the UK Society for General Microbiology (SGM) Eukaryotic Microbiology division committee and serves as an associate editor of the ISHAM journal Medical Mycology. Her current research interests are host-fungus interactions, modelling fungal disease, the 3Rs in fungal research and antifungal therapy & resistance.

Contact:
Dr Donna MacCallum PhD
Senior Lecturer
Aberdeen Fungal Group
School of Medical Sciences
University of Aberdeen
Institute of Medical Sciences
Foresterhill
Aberdeen
UK
AB25 2ZD

Tel: +44 1224 437425
Fax: +44 1224 437465

 

President-elect

Malcolm Richardson is the Director of the Mycology Reference Centre Manchester which is an integral part of the National Aspergillosis Centre, based at the University Hospital of South Manchester; and an honorary Professor of Medical Mycology at the University of Manchester. His clinical and laboratory investigations over the past 40 years have focused on the pathogenicity, diagnosis and epidemiology of superficial and systemic fungal infections. More recently he has applied his diagnostic interests to investigating the role of moulds in “sick building syndrome”. His professional duties include being the Editor-in-Chief of Critical Reviews in Microbiology , and acting as a consultant for the European Food Safety Authority and the WHO. He is a co-author of Fungal infection: Diagnosis and Management, 4th Edition (2012).

 

Contact

Professor Malcolm Richardson, PhD, FSB, FRCPath

Director and Consultant Clinical Mycologist - Mycology Reference Centre Manchester

Professor of Medical Mycology – University of Manchester

Editor-in-Chief – Critical Reviews in Microbiology

Mycology Reference Centre Manchester

Education and Research Centre

University Hospital of South Manchester (Wythenshawe Hospital)

Southmoor Road

Manchester M23 9LT

UK.

Tel: +44-161-291-5914

 

Past President

David Ellis is Head of the Mycology Unit at the Adelaide Women's and Children's Hospital and an Associate Professor in the School of Molecular and Biomedical Science at the University of Adelaide.  His current research interests are the epidemiology and ecology of medically important fungi, especially Cryptococcus, Candida, Scedosporium and the dermatophytes, fungal taxonomy and antifungal susceptibility testing.

 

Contact

A/Prof David Ellis
Mycology Unit
Women's and Children's Hospital,
72 King William Road
North Adelaide 5006 Australia
Tel:  +61 8 8161 6459

Sybren de Hoog
 

Vice President

Bernard Hube is Head of the Department of "Microbial Pathogenicity Mechanisms" link at the Hans Knoell Institute (HKI), a German Leibniz Institute which investigates the infection biology of human pathogenic fungi, and Professor at the Friedrich Schiller University (FSU) of Jena, Germany. His major research interest are the molecular pathogenicity mechanisms of infections with Candida albicans and C. glabrata. His current research is focussed on functional genomics, host-pathogen interactions, infection models, extracellular enzymes, regulatory proteases, morphology, virulence associated genes, iron and zinc acquisition, and microevolution. In addition to ISHAM, he is member of several microbial societies (DMykG, DGHM, ASM, VAAM) and editorial boards. He is active member of the DFG priority program 1580 link, the Center for Sepsis Control and Care (CSCC) link, the International Leibniz Research School  (ILRS) link, the Jena School for Microbial Communication (JSMC) link: link, the European network ERA-NET PathoGenoMics CandiCol link and the Marie Curie Initial Training Network FINSysB link.

 

Contact
Prof. Dr. Bernhard Hube
Department of Microbial Pathogenicity Mechanisms,
Leibniz Institute for Natural Product Research and Infection Biology –
Hans Knoell Institute Jena (HKI)
Beutenbergstraße 11a
D-07745 Jena, Germany
Phone + 49(0)3641 532 1401 or 00
Fax + 49(0)3641 532 0810
webpage

 

Vice President

David Denning is an infectious diseases clinician with expertise in fungal diseases, working in an academic respiratory medicine department in a University hospital.  He manages the National Aspergillosis Centre, Manchester which is the referral centre in the UK for all patients with chronic pulmonary aspergillosis (a population of 61 million).  His group undertakes basic research (genomics, pathogenesis and mechanisms of antifungal drug resistance), applied laboratory work (molecular and serological diagnostics), and clinical studies (description of the natural history of fungal infection, human genetics of aspergillosis and therapy studies). His current foci of interest are chronic and allergic pulmonary fungal disease, the global burden of fungal infection and azole resistance in Aspergillus.  He has published more than 400 papers, books and book chapters, including an undergraduate textbook of Medicine. His work has been cited over 22,000 times. He is the Founder of 2 University spinout biotechnology companies – F2G Ltd (antifungal drug discovery and development) and Myconostica Ltd (molecular diagnostic tests for fungi), now sold to Lab21. He is the managing Editor of The Aspergillus Website (1998-) with  over 1 million pages read per month. He has chaired the Scientific Committees of several international fungal infection meetings, and co-chairs the alternate year Advances Against Aspergillosis meetings, attracting ~400 delegates for >120 countries. He leads LIFE (Leading Internal Fungal Education) which is focused on improving patient outcomes through advocacy and education.

 

Contact

Professor David Denning

FRCP FRCPath FIDSA DCH FMedSci

Professor of Medicine and Medical Mycology, University of Manchester

Director, National Aspergillosis Centre, University Hospital of South Manchester (Wythenshawe)

Manchester, UK



 

Vice President

Wieland Meyer is the Head of the Molecular Mycology Research Laboratory and Associate Professor at the Center for Infectious Diseases and Microbiology, Sydney Medical School – Westmead Hospital, Westmead Millennium Institute and the Sydney Institute of Emerging Infectious Diseases and Biosecurity of the University of Sydney, Sydney Australia. His research focuses on the evolution, phylogeny, speciation, population genetics, molecular epidemiology and typing, of human pathogenic fungi (especially of the genera Candida, Cryptococcus, Scedosporium and Pneumocystis), the development of fast, simple and reliable molecular identification techniques for human/animal fungal pathogens, and the understanding of fungal pathogenesis on a molecular level. He is the curator of the Westmead Hospital Medical Mycology Culture Collection. In addition to ISHAM he is also a member of the executive committee of the International Mycological Association (IMA) and the chair of the organizing committee of the next ISHAM congress 4-8.5.2015 in Melbourne Australia. He is currently associate editor of the journals: Medical Mycology, Personia-Molecular Phylogeny and Evolution of Fungi, Australasian Mycologist, Microbiology Australia and IMA Fungus.

 

Contact

Prof. Dr. rer. nat. Wieland Meyer
Molecular Mycology Research Laboratory
CIDM, ICPMR, Level 3, Room 3114A
Sydney Medical School - Westmead Hospital
Darcy Road
Westmead, NSW, 2145
Phone + 61-2-98456895
Fax + 61-2-98915317
Email: wieland.meyer@sydney.edu.au

webpages: www.mycologylab.org
                mlst.mycologylab.org

 

 

Vice President

Ruth Ashbee

Ruth Ashbee is Principal Clinical Scientist at the Mycology Reference Centre, Leeds and Visiting Lecturer at the University of Leeds, UK. She is also Adjunct Faculty in the Department of Microbiology, Christian Medical College, Vellore, India. She is involved in all aspects of clinical mycology within the Mycology Reference Centre and has recently set up a therapeutic drug monitoring service for the azoles within the laboratory. Her research interests focus on Malassezia, therapeutic drug monitoring of the azoles and teaching and training in mycology.  She has been Director of the biennial British Society for Medical Mycology course in diagnostic medical mycology since 1998.

 


Contact

 

Vice President

Shigeru Kohno received his M.D. and Ph.D. degrees from Nagasaki University School of Medicine in Nagasaki, Japan in 1974 and 1980, respectively. He joined the Department of Pathology, University of New Mexico, U.S.A. as a research associate from 1980 to 1982, and National Institutes of Health in Bethesda, Maryland, U.S.A. as a visiting scientist between 1993 and 1994. In 1996, he became Professor of 2nd Department of Internal Medicine, Nagasaki University School of Medicine, and promoted to Chairman of Graduate School of Medical Sciences and also Dean of Nagasaki University School of Medicine in 2000 and 2006, respectively. From April 2009, he started to serve as Trustee of Nagasaki University as well as Director of Nagasaki University Hospital. His major research interests are fungal including Cryptococcus, Candida and Aspergillus, and bacterial infections and have developed several clinical guidelines of respiratory infections including pneumonia and fungal infection in Japan.

 

Contact
As of July 6, 2012
Prof. Dr. Shigeru Kohno
Department of Molecular Microbiology and Immunology
Nagasaki University Graduate School of Biomedical Sciences
1-7-1 Sakamoto
Nagasaki 852-8501, JAPAN
Phone: +81-95-819-7273
Fax: +81-95-849-7285
E-mail: s-kohno@nagasaki-u.ac.jp
URL: http://www.med.nagasaki-u.ac.jp/intmed-2/english/index.html

 

Journal Editor - Medical Mycology

Ira Salkin is currently a private consultant with his own firm, Information From Science LLC and adjunct associate professor in the Department of Biomedical Sciences of the School of Public Health, State University of New York at Albany.  He formerly served in the New York State Department of Health in several roles including the Director of the state's Medical Mycology Diagnostic Laboratory and mycology proficiency testing program.  He is the Editor-in-Chief of Medical Mycology, the official journal of the International Society for Human and Animal Mycology.

 

Contact

Dr. I.F. Salkin,
Information From Science LLC,
PO Box 408,
West Sand Lake, NY  12196,
Voice/Fax: 1-518-674-1713,

 

Journal Editor - Medical Mycology Case Reports

Oliver Kurzai is an MD specialized in microbiology, virology and epidemiology of infection. He is full professor and head of the Fungal Septomics research group at the Friedrich-Schiller-University and the Leibniz-Institute for Natural Products Research and Infection Biology (Hans-Knöll-Institute), in Jena, Germany. His major research fields are infection-biology and innate immune recognition of pathogenic fungi and Neisseria species. He is elected Secretary of the German speaking Mycological Society of Mycology. In 2012 he was appointed as Editor-in-Chief of Medical Mycology Case Reports.

 

Contact

Prof. Dr. Oliver Kurzai
Fungal Septomics
Leibniz Institute for Natural Product Research and Infection Biology –
Hans Knoell Institute Jena (HKI)
Beutenbergstraße 11a
D-07745 Jena, Germany

Phone: +49(0)3641 532 1374 or 1380
Fax: +49(0)3641 532 2374

 

"Chair, Young ISHAM"

Michaela Lackner (ELA) is postdoc of Prof. Dr. med. Cornelia
Lass-Flörl at the Division of Hygiene and Medical Microbiology
Mycology, Innsbruck Medical University, Austria. Her current research
interests are (1) establishing molecular diagnostic assays for
medically important fungi, especially Aspergillus spp. and
Scedosporium spp., (2) fungal taxonomy and typing of Scedosporium spp.
and Aspergillus spp., (3) antifungal susceptibility testing and
resistance gene analyses of Candida and Aspergillus species.

Contact
Mag. Dr. rer. nat. Michaela Lackner
Division of Hygiene and Medical Microbiology
Innsbruck Medical University
Fritz-Pregl-Strasse 3/III
A-6020 Innsbruck
Austria
Michaela. Lackner@i-med.ac.at
Tel:  +43 512 9003 70725